{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:13:54Z","timestamp":1789683234893,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773787"],"award-info":[{"award-number":["81773787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2018ZX10301101"],"award-info":[{"award-number":["2018ZX10301101"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118427","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T15:07:40Z","timestamp":1600096060000},"page":"118427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-\u03baB pathway"],"prefix":"10.1016","volume":"267","author":[{"given":"Wanzhen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuben","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118427_bb0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/327710a0","article-title":"An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells","volume":"327","author":"Stricker","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118427_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118427_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/088922202753614191","article-title":"Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy","volume":"18","author":"Harrold","year":"2002","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.lfs.2020.118427_bb0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2567.2010.03375.x","article-title":"Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells","volume":"132","author":"Huang","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2020.118427_bb0025","first-page":"665","article-title":"Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium","volume":"24","author":"Al-Harti","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.lfs.2020.118427_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/QCO.0000000000000026","article-title":"Emerging strategies to deplete the HIV reservoir","volume":"27","author":"Archin","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118427_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: Shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2020.118427_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2020.118427_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2012.05.003","article-title":"The development of immune-modulating compounds to disrupt HIV latency","volume":"23","author":"Remoli","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2020.118427_bb0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"18","author":"Xing","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2020.118427_bb0055","series-title":"Nature","article-title":"Author correction: robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8(+) cells","author":"McBrien","year":"2020"},{"key":"10.1016\/j.lfs.2020.118427_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/intimm\/1.1.43","article-title":"Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes","volume":"1","author":"Shibuya","year":"1989","journal-title":"Int. Immunol."},{"key":"10.1016\/j.lfs.2020.118427_bb0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.1601254","article-title":"Effect of IL-7 therapy on phospho-ribosomal protein S6 and TRAF1 expression in HIV-specific CD8 T cells in patients receiving antiretroviral therapy","volume":"200","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118427_bb0070","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.181.11.7713","article-title":"An in vitro system to model the establishment and reactivation of HIV-1 latency","volume":"181","author":"Marini","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118427_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/srep12442","article-title":"Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kB-dependent mechanism","volume":"5","author":"Diaz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118427_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2019.04.005","article-title":"A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b","volume":"164","author":"Liang","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118427_bb0085","first-page":"93","article-title":"Specific activation in vivo of HIV-1 by a bromodomain inhibitor from monocytic cells in humanized mice under antiretroviral therapy","author":"Li","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.118427_bb0090","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1093\/nar\/gkx550","article-title":"Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency","volume":"45","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2020.118427_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2334\/josnusd.53.1","article-title":"Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression","volume":"53","author":"Imai","year":"2011","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.lfs.2020.118427_bb0100","first-page":"24","article-title":"Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines","volume":"11","author":"Qu","year":"2013","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.lfs.2020.118427_bb0105","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-kappaB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118427_bb0110","doi-asserted-by":"crossref","first-page":"ofw189","DOI":"10.1093\/ofid\/ofw189","article-title":"Ongoing clinical trials of human immunodeficiency virus latency-reversing and immunomodulatory agents","volume":"3","author":"Delagreverie","year":"2016","journal-title":"Open forum infectious diseases"},{"key":"10.1016\/j.lfs.2020.118427_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0960-9822(06)00183-7","article-title":"Cell growth inhibition by the mad\/max complex through recruitment of histone deacetylase activity","volume":"7","author":"Sommer","year":"1997","journal-title":"Current biology: CB"},{"key":"10.1016\/j.lfs.2020.118427_bb0120","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1073\/pnas.75.5.2239","article-title":"Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences","volume":"75","author":"Vidali","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118427_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.lfs.2020.118427_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molmed.2015.11.004","article-title":"HIV-1 eradication: early trials (and tribulations)","volume":"22","author":"Spivak","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2020.118427_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2020.118427_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1358\/dot.2017.53.3.2595452","article-title":"Chidamide tablets: HDAC inhibition to treat lymphoma","volume":"53","author":"Xu","year":"2017","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.lfs.2020.118427_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2017.03.064","article-title":"Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors","volume":"133","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118427_bb0150","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118427_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1568026619666190122144949","article-title":"Zinc-dependent deacetylase (HDAC) inhibitors with different zinc binding groups","volume":"19","author":"Li","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118427_bb0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-7-266","article-title":"Cell line-dependent variability in HIV activation employing DNMT inhibitors","volume":"7","author":"Fernandez","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2020.118427_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-016-0637-9","article-title":"Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412","volume":"13","author":"Ao","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2020.118427_bb0170","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/endo.131.4.1396312","article-title":"Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase","volume":"131","author":"Tilly","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2020.118427_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/excr.1997.3778","article-title":"U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation","volume":"238","author":"Brockhaus","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2020.118427_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/v4020309","article-title":"Novel approaches to inhibit HIV entry","volume":"4","author":"Didigu","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2020.118427_bb0185","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2017.01981","article-title":"The expanding therapeutic perspective of CCR5 blockade","volume":"8","author":"Vangelista","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.118427_bb0190","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2020.118427_bb0195","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118427_bb0200","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1699273","article-title":"Molecular targets for AIDS therapy","volume":"249","author":"Mitsuya","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118427_bb0205","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.7532321","article-title":"Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors","volume":"267","author":"Spence","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118427_bb0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118427_bb0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo","volume":"578","author":"Nixon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118427_bb0220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.3277274","article-title":"The human immunodeficiency virus: infectivity and mechanisms of pathogenesis","volume":"239","author":"Fauci","year":"1988","journal-title":"Science."},{"key":"10.1016\/j.lfs.2020.118427_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004071","article-title":"Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing","volume":"10","author":"Wei","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2020.118427_bb0230","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118427_bb0235","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/jiu155","article-title":"HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat","volume":"210","author":"Archin","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118427_bb0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/cit813","article-title":"A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy","volume":"58","author":"Spivak","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.lfs.2020.118427_bb0245","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.micinf.2017.10.003","article-title":"Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus","volume":"20","author":"Yang","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2020.118427_bb0250","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jmv.25207","article-title":"Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation","volume":"90","author":"Kuai","year":"2018","journal-title":"J. Med. Virol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520311802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520311802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T03:22:40Z","timestamp":1719890560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520311802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":50,"alternative-id":["S0024320520311802"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118427","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118427"}}